Next Financial Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Next Financial Group’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$4K	Sell	105 -100	-49%	-$4.46K	﹤0.01%	2490
2021 Q3	$10K	Buy	205 +100	+95%	+$4.59K	﹤0.01%	2033
2021 Q2	$5K	Hold	105	–	–	﹤0.01%	2211
2021 Q1	$5K	Hold	105	–	–	﹤0.01%	2118
2020 Q4	$5K	Hold	105	–	–	﹤0.01%	1999
2020 Q3	$4K	Buy	+105	New	+$4.33K	﹤0.01%	1923
2020 Q2	–	Sell	-105	Closed	-$3K	–	1649
2020 Q1	$3K	Hold	105	–	–	﹤0.01%	1856
2019 Q4	$4K	Hold	105	–	–	﹤0.01%	2034
2019 Q3	$3K	Hold	105	–	–	﹤0.01%	2038
2019 Q2	$4K	Buy	+105	New	+$3.62K	﹤0.01%	1965
2016 Q4	–	Sell	-1,734	Closed	-$45K	–	2467
2016 Q3	$45K	Buy	1,734 +601	+53%	+$15K	0.01%	995
2016 Q2	$25K	Buy	1,133 +201	+22%	+$4.77K	0.01%	888
2016 Q1	$20K	Sell	932 -307	-25%	-$7.02K	0.01%	938
2015 Q4	$39K	Hold	1,239	–	–	0.01%	698
2015 Q3	$34K	Buy	+1,239	New	+$43.2K	0.01%	770

Other funds holding SBIO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Next Financial Group's SBIO Position: Q4 2021 in Review

Next Financial Group reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 49% in Q4 2021, selling an estimated $4.46K and leaving 105 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Next Financial Group first reported a position in SBIO in Q3 2015 and has held it in 15 quarters since. The position peaked at $45K in Q3 2016. 66 funds tracked by Wall St. Rank hold SBIO as of Q4 2021.

Next Financial Group held 105 shares of ALPS Medical Breakthroughs ETF worth $4K as of Q4 2021.
Next Financial Group sold 100 ALPS Medical Breakthroughs ETF shares in Q4 2021, an estimated $4.46K.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2490 holding.
Next Financial Group first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and has held it in 15 quarters since.
Next Financial Group's ALPS Medical Breakthroughs ETF position peaked at $45K in Q3 2016.
66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.